Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection

Hepatitis B e antigen (HBeAg) is a widely used marker both for chronic hepatitis B (CHB) clinical management and HBV-related basic research. However, due to its high amino acid sequence homology to hepatitis B core antigen (HBcAg), most of available anti-HBe antibodies are cross-reactive with HBcAg...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shao-Juan, Chen, Zi-Min, Wei, Min, Liu, Jia-Qi, Li, Zong-Lin, Shi, Tian-Shu, Nian, Sheng, Fu, Rao, Wu, Yang-Tao, Zhang, Ya-Li, Wang, Ying-Bin, Zhang, Tian-Ying, Zhang, Jun, Xiong, Jun-Hui, Tong, Shu-Ping, Ge, Sheng-Xiang, Yuan, Quan, Xia, Ning-Shao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832009/
https://www.ncbi.nlm.nih.gov/pubmed/33296295
http://dx.doi.org/10.1080/22221751.2020.1862631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832009/
https://www.ncbi.nlm.nih.gov/pubmed/33296295
http://dx.doi.org/10.1080/22221751.2020.1862631

Ejemplares similares